{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:24:36Z","timestamp":1792542276611,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urology.2026.01.035","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:04:12Z","timestamp":1770224652000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diagnostic Performance of Urinary Biomarker Tests in Detecting Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis"],"prefix":"10.1016","volume":"210","author":[{"given":"Fernando","family":"Siguencia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ahdoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-4223","authenticated-orcid":false,"given":"Charles J.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.01.035_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2026.01.035_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2026.01.035_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2217\/14796694.3.6.595","article-title":"Anatomical location of urothelial carcinomas of the urinary tract leads to perspectives of specific treatment","volume":"3","author":"Roupr\u00eat","year":"2007","journal-title":"Future Oncol"},{"key":"10.1016\/j.urology.2026.01.035_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/SPC.0b013e3283552d19","article-title":"Metastatic bladder cancer: anything new?","volume":"6","author":"Calabro","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.urology.2026.01.035_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideeline: 2024 amendment","volume":"211","author":"Holzbeirlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib6","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.21037\/tcr-20-1990","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.urology.2026.01.035_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2026.01.035_bib9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.urology.2026.01.035_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-5347(17)69643-5","article-title":"Cytology of the urine sediment in neoplasms of the urinary tract","volume":"57","author":"Papanicolaou","year":"1947","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib11","first-page":"163","article-title":"Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer","volume":"37","author":"Wiener","year":"1993","journal-title":"ActaCytol"},{"key":"10.1016\/j.urology.2026.01.035_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0094-0143(21)01216-7","article-title":"Urine cytology of transitional cell neoplasms","volume":"6","author":"Rife","year":"1979","journal-title":"UrolClin North Am"},{"key":"10.1016\/j.urology.2026.01.035_bib13","first-page":"1","article-title":"Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers","volume":"24","author":"Flores Monar","year":"2023","journal-title":"Int\u00a0J\u00a0Mol\u00a0Sci"},{"key":"10.1016\/j.urology.2026.01.035_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/BLC-230096","article-title":"Noninvasive tests for bladder cancer detection and surveillance: a systematic review of commercially available assays","volume":"10","author":"Heard","year":"2024","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2026.01.035_bib15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2026.01.035_bib16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/M22-0276","article-title":"QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies","volume":"175","author":"Lee","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2026.01.035_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urology.2026.01.035_bib18","first-page":"882","article-title":"Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement","volume":"5","author":"Reid","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.urology.2026.01.035_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00345-012-0935-9","article-title":"Urinary BTA: indicator of bladder cancer or of hematuria","volume":"30","author":"Miyake","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1097-0339(199907)21:1<27::AID-DC8>3.0.CO;2-8","article-title":"Utility of the BTA stat test kit for bladder cancer screening","volume":"21","author":"Nasuti","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.urology.2026.01.035_bib21","doi-asserted-by":"crossref","first-page":"484.e17","DOI":"10.1016\/j.urolonc.2023.06.013","article-title":"BTA stat\u00ae, NMP22\u00ae BladderChek\u00ae, UBC\u00ae Rapid Test, and CancerCheck\u00ae UBC\u00ae rapid VISUAL as urinary marker for bladder cancer: final results of a German multicenter study","volume":"41","author":"Ecke","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.01.035_bib22","first-page":"55","article-title":"Inclusion of a molecular marker of bladder cancer in a clinical pathway for investigation of haematuria may reduce the need for cystoscopy","volume":"132","author":"Davidson","year":"2019","journal-title":"NZ Med J"},{"key":"10.1016\/j.urology.2026.01.035_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12894-015-0018-5","article-title":"A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma","volume":"15","author":"Kavalieris","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/JU.0000000000003991","article-title":"A multicenter prospective randomized controlled trial comparing cxbladder triage to cystoscopy in patients with microhematuria: the safe testing of risk for asymptomatic microhematuria trial","volume":"212","author":"Lotan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib25","doi-asserted-by":"crossref","first-page":"65.e13","DOI":"10.1016\/j.urolonc.2025.10.008","article-title":"Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: the multicenter, prospective, observational DRIVE study","volume":"44","author":"Savage","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2026.01.035_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/JU.0000000000003211","article-title":"Urinary Analysis of FGFR3 and TERT gene mutations enhances performance of cxbladder tests and improves patient risk stratification","volume":"209","author":"Peng","year":"2023","journal-title":"Lett\u00a0J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib27","first-page":"12489","article-title":"Bladder epicheck test: a novel tool to support urothelial carcinoma diagnosis in urine samples","volume":"24","author":"Fiorentino","year":"2023","journal-title":"Int\u00a0J\u00a0Mol\u00a0Sci"},{"key":"10.1016\/j.urology.2026.01.035_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the bladder EpiCheckTM methylation test for patients under surveillance for nonmuscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2026.01.035_bib29","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.clgc.2022.03.009","article-title":"The role of Bladder Epicheck test in follow-up of patients with non-muscle invasive bladder cancer","volume":"20","author":"Ragonese","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urology.2026.01.035_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2490-12-23","article-title":"Influencing factors on the NMP-22 urine assay: an experimental model","volume":"12","author":"Miyake","year":"2012","journal-title":"BMC Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-5347(05)65965-4","article-title":"Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors","volume":"166","author":"Giannopoulos","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jama.293.7.810","article-title":"Detection of bladder cancer using a point-of-care proteomic assay","volume":"293","author":"Grossman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2026.01.035_bib33","article-title":"Analytical validation of ONCURIA\u2122 a multiplex bead-based immunoassay for the non-invasive bladder cancer detection","volume":"22","author":"Furuya","year":"2020","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.urology.2026.01.035_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12967-025-06749-z","article-title":"Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting","volume":"23","author":"Pagano","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.urology.2026.01.035_bib35","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1158\/1055-9965.EPI-16-0260","article-title":"A nomogram derived by combination of demographic and biomarker data improves the noninvasive evaluation of patients at risk for bladder cancer","volume":"25","author":"Huang","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2026.01.035_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/dc.23686","article-title":"The value of the UroVysion\u00ae FISH assay in the risk-stratification of patients with \"atypical urothelial cells\" in urinary cytology specimens","volume":"45","author":"Virk","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.urology.2026.01.035_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.0956-5507.2003.00094.x","article-title":"Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma","volume":"14","author":"Mian","year":"2003","journal-title":"Cytopathology"},{"key":"10.1016\/j.urology.2026.01.035_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncy.21327","article-title":"Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation","volume":"121","author":"Dimashkieh","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.urology.2026.01.035_bib39","article-title":"Development and validation of an artificial intelligence-based model for detecting urothelial carcinoma using urine cytology images: a multicentre, diagnostic study with prospective validation","volume":"71","author":"Wu","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.urology.2026.01.035_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bju.14019","article-title":"Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance","volume":"121","author":"Pichler","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2026.01.035_bib41","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00345-021-03629-1","article-title":"Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up","volume":"39","author":"Cancel-Tassin","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.eururo.2018.11.055","article-title":"Prospective validation of an mRNA-based urine test for surveillance of patients with bladder cancer","volume":"75","author":"van Valenberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/JU.0000000000004490","article-title":"Updates to microhematuria: AUA\/SUFU Guideline (2025)","volume":"213","author":"Barocas","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.035_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eururo.2019.04.035","article-title":"Evaluation of Cxbladder and adjudication of atypical cytology and equivocal cystoscopy","volume":"76","author":"Konety","year":"2019","journal-title":"Eur Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:57:26Z","timestamp":1777474646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S0090429526000749"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.01.035","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Performance of Urinary Biomarker Tests in Detecting Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}